lobbying_activities: 1630071

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1630071	cca30f28-2661-4fac-8737-fd9a745cfed9	Q4	SLC HEALTH STRATEGIES, LLC	401018877	EISAI INC.	2014	fourth_quarter	PHA	Obesity product matters as well as FDA funding HR 4299 --Improving Regulatory Transparency for New Medical Therapies Act re: DEA scheduling of controlled substances S. 2862 - Transparency, Patient Access, and Effective Drug Enforcement Act of 2014 re: DEA scheduling of controlled substances	HOUSE OF REPRESENTATIVES,SENATE	40500		0	0	2015-01-19T15:22:19.437000-05:00